CLL/MCL Coverage from Every Angle
ABOUT
SECTIONS
JNCCN Spotlights
Videos
News
Medical Literature
CE Activities
Clinical Trials
For Your Patients
NCCN RESOURCES
NCCN Guidelines
®
NCCN Compendium
®
NCCN Templates
®
NCCN Guidelines for Patients®
360 HUB
Advanced Skin Cancers
CLL/MCL
Multiple Myeloma
Non–Small Cell Lung Cancer
Ovarian Cancer
JNCCN
Editor:
Jeremy S. Abramson, MD, MMSc
Advertisement
Advertisement
Available Clinical Trials
University of Nebraska
Siteman Cancer Center
Dana-Farber Cancer Institute
Duke Cancer Institute
Fox Chase Cancer Center
The Sidney Kimmel Comprehensive Cancer Center
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center
The Ohio State University Comprehensive Cancer Center
Stanford Cancer Institute
The University of Alabama at Birmingham Comprehensive Cancer Center
UC San Diego Moores Cancer Center
Helen Diller Family Comprehensive Cancer Center
University of Colorado Cancer Center
University of Michigan Comprehensive Cancer Center
MD Anderson Cancer Center
University of Wisconsin Carbone Cancer Center
JNCCN Spotlights
?
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Update Venetoclax in CLL
View More >
Advertisement
Resources
For your Patients
Copyright ©
2026
National Comprehensive Cancer Network, All Rights Reserved